| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-02 22:16:33 UTC |
|---|
| Updated at | 2022-09-02 22:16:33 UTC |
|---|
| NP-MRD ID | NP0163586 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (4s)-3,4-bis[(3-hydroxyphenyl)methyl]oxolan-2-one |
|---|
| Description | Enterolactone, also known as BHMDF or 2,3-BHBB, belongs to the class of organic compounds known as dibenzylbutyrolactone lignans. These are lignan compounds containing a 3,4-dibenzyloxolan-2-one moiety. (4s)-3,4-bis[(3-hydroxyphenyl)methyl]oxolan-2-one is found in Linum usitatissimum. (4s)-3,4-bis[(3-hydroxyphenyl)methyl]oxolan-2-one was first documented in 2022 (PMID: 35633575). Based on a literature review a small amount of articles have been published on Enterolactone (PMID: 35914449) (PMID: 35757242) (PMID: 35745107) (PMID: 35532015). |
|---|
| Structure | OC1=CC(C[C@@H]2COC(=O)C2CC2=CC=CC(O)=C2)=CC=C1 InChI=1S/C18H18O4/c19-15-5-1-3-12(8-15)7-14-11-22-18(21)17(14)10-13-4-2-6-16(20)9-13/h1-6,8-9,14,17,19-20H,7,10-11H2/t14-,17?/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 2,3-Bis(3'-hydroxybenzyl)butyrolactone, (trans)-(+-)-isomer | MeSH | | BHMDF | MeSH | | 2,3-BHBB | MeSH | | 2,3-Bis(3'-hydroxybenzyl)butyrolactone | MeSH | | 3,4-Bis((3-hydroxyphenyl)methyl)dihydro-2-(3H)-furanone | MeSH | | trans-2,3-Bis(3-hydroxybenzyl)-gamma-butyrolactone | MeSH | | 2,3-Bis(3'-hydroxybenzyl)butyrolactone, (trans)-isomer | MeSH | | HPMF | MeSH |
|
|---|
| Chemical Formula | C18H18O4 |
|---|
| Average Mass | 298.3380 Da |
|---|
| Monoisotopic Mass | 298.12051 Da |
|---|
| IUPAC Name | (4S)-3,4-bis[(3-hydroxyphenyl)methyl]oxolan-2-one |
|---|
| Traditional Name | (4S)-3,4-bis[(3-hydroxyphenyl)methyl]oxolan-2-one |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | OC1=CC(C[C@@H]2COC(=O)C2CC2=CC=CC(O)=C2)=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C18H18O4/c19-15-5-1-3-12(8-15)7-14-11-22-18(21)17(14)10-13-4-2-6-16(20)9-13/h1-6,8-9,14,17,19-20H,7,10-11H2/t14-,17?/m1/s1 |
|---|
| InChI Key | HVDGDHBAMCBBLR-XPCCGILXSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dibenzylbutyrolactone lignans. These are lignan compounds containing a 3,4-dibenzyloxolan-2-one moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lignans, neolignans and related compounds |
|---|
| Class | Furanoid lignans |
|---|
| Sub Class | Tetrahydrofuran lignans |
|---|
| Direct Parent | Dibenzylbutyrolactone lignans |
|---|
| Alternative Parents | |
|---|
| Substituents | - Dibenzylbutyrolactone
- Lignan lactone
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Monocyclic benzene moiety
- Gamma butyrolactone
- Benzenoid
- Oxolane
- Carboxylic acid ester
- Lactone
- Carboxylic acid derivative
- Oxacycle
- Organoheterocyclic compound
- Monocarboxylic acid or derivatives
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Organooxygen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Hamdi T, Gouissem I: Potential effect of Enterolactone and Raloxifene in reversing osteoarthritis markers in cultured human articular chondrocytes. ARP Rheumatol. 2022 Jan-Mar;1(1):30-41. [PubMed:35633575 ]
- Yu L, Xu Q, Wang P, Luo J, Zheng Z, Zhou J, Zhang L, Sun L, Zuo D: Secoisolariciresinol diglucoside-derived metabolite, enterolactone, attenuates atopic dermatitis by suppressing Th2 immune response. Int Immunopharmacol. 2022 Oct;111:109039. doi: 10.1016/j.intimp.2022.109039. Epub 2022 Jul 29. [PubMed:35914449 ]
- Castellano-Escuder P, Gonzalez-Dominguez R, Vaillant MF, Casas-Agustench P, Hidalgo-Liberona N, Estanyol-Torres N, Wilson T, Beckmann M, Lloyd AJ, Oberli M, Moinard C, Pison C, Borel JC, Joyeux-Faure M, Sicard M, Artemova S, Terrisse H, Dancer P, Draper J, Sanchez-Pla A, Andres-Lacueva C: Assessing Adherence to Healthy Dietary Habits Through the Urinary Food Metabolome: Results From a European Two-Center Study. Front Nutr. 2022 Jun 9;9:880770. doi: 10.3389/fnut.2022.880770. eCollection 2022. [PubMed:35757242 ]
- Mullens DA, Ivanov I, Hullar MAJ, Randolph TW, Lampe JW, Chapkin RS: Personalized Nutrition Using Microbial Metabolite Phenotype to Stratify Participants and Non-Invasive Host Exfoliomics Reveal the Effects of Flaxseed Lignan Supplementation in a Placebo-Controlled Crossover Trial. Nutrients. 2022 Jun 8;14(12):2377. doi: 10.3390/nu14122377. [PubMed:35745107 ]
- Tse TJ, Guo Y, Shim YY, Purdy SK, Kim JH, Cho JY, Alcorn J, Reaney MJT: Availability of bioactive flax lignan from foods and supplements. Crit Rev Food Sci Nutr. 2023;63(29):9843-9858. doi: 10.1080/10408398.2022.2072807. Epub 2022 May 9. [PubMed:35532015 ]
- LOTUS database [Link]
|
|---|